Ciprofloxacin/Gatifloxacin‐1,2,3‐triazole‐isatin Hybrids and Their In Vitro Anticancer Activity
Author:
Affiliation:
1. School of Nuclear Technology and Chemistry & BiologyHubei University of Science and Technology Xianning Hubei China
Funder
Campus Research Project of Hubei University of Science and Technology
Publisher
Wiley
Subject
Organic Chemistry
Link
https://onlinelibrary.wiley.com/doi/pdf/10.1002/jhet.3684
Reference23 articles.
1. World Health Organization.Latest global cancer data: cancer burden rises to 18.1 million new cases and 9.6 million cancer deathsin2018.
2. World Health Organization.Cancer control: knowledge into action2006.https://www.who.int/cancer/modules/ModulesFlyer.pdf?ua=1
3. World Health Organization.Cancer: key facts2018.https://www.who.int/en/news‐room/fact‐sheets/detail/cancer
4. Anticancer and Reversing Multidrug Resistance Activities of Natural Isoquinoline Alkaloids and their Structure-activity Relationship
5. Recent advances (2015–2016) in anticancer hybrids
Cited by 5 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Benzimidazole and piperidine containing novel 1,2,3‐triazole hybrids as anti‐infective agents: Design, synthesis, in silico and in vitro antimicrobial efficacy;Journal of Biochemical and Molecular Toxicology;2023-09-05
2. Recent Advances in Synthesis and Anticancer Potential of Triazole-Containing Scaffolds;Anti-Cancer Agents in Medicinal Chemistry;2022-08-04
3. Therapeutic Outcomes of Isatin and Its Derivatives against Multiple Diseases: Recent Developments in Drug Discovery;Pharmaceuticals;2022-02-22
4. 1,2,3-Triazole-Containing Compounds as Anti–Lung Cancer Agents: Current Developments, Mechanisms of Action, and Structure–Activity Relationship;Frontiers in Pharmacology;2021-06-11
5. Iodine mediated synthesis of some new imidazo[1,2‐a]pyridine derivatives and evaluation of their antimicrobial activity;Journal of Heterocyclic Chemistry;2020-03-17
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3